President Elect Rashmi Kanagal-Shamanna, MD explains the importance of a comprehensive work up (NGS+CMA) for those presenting with cytopenias for accurate diagnosis of CCUS. 42% by NGS had a CCUS defining mutation while 39% had one by CMA. #CGCAnnual2023

Technologist Award winner Nguyen: CMA is a feasible alternative to chromosome analysis in cases of hypocellular MDS. CMA provides valuable prognosis information in cases with incomplete karyotype #CGCAnnual2023

Wrapping up Day 2 at the 2023 Cancer Genomics Consortium Annual Event with a lineup of truly remarkable presentations. Looking forward to even more insights and discussions tomorrow! 📚🧬 #CGCAnnual2023 #CancerGenomics #InnovationInTheMaking

Happening now…first CGC social event for all #CGCAnnual2023 attendees. Join us. Cancer Genomics Consortium (CGC) #bionano #steminist

#CGCAnnual2023 Day 3: Dr. Guillermo Garcia-Manero delivered a fabulous keynote on unlocking the power of genomics, cytogenomics & transcriptomics for MDS therapy🌟✨💫. His expertise & engaging insights left the audience inspired & excited about the future of cancer Rx 🧬

An immensely informative and invigorating invited speaker session at #CGCAnnual2023 by Dr. Joseph Khoury. A deep dive into the TP53 altered myeloid malignancies, an up-to-date and future perspectives 🌟💫✨#CGCAnnual2023 Day 3.

Captivating 2nd Spotlight Scientific Symposium at #CGCAnnual2023! Very informative session by Dr. Dilani Lokuhetty from IARC & Jennelle C. Hodge on the WHO/IARC Overview and the exciting collaborations with the Cancer Genomics Consortium Cancer Genomics Consortium (CGC)

Fantastic presentation by Dr. Jason Saliba on behalf of the Oncogenic assessment of FLT3 Variants by the @ClinGen FLT3 Somatic Cancer Variant Curation Expert Panel #CGCAnnual2023

Wrapping up day 3 of #CGCAnnual2023 with a remarkable finale: the final scientific spotlight symposium showcasing Dr. Jeremy Segal talking about the GOAL Consortium. Cancer Genomics Consortium (CGC)

We’re looking forward to see where Cancer Genomics Consortium (CGC) goes in the future with incoming President Rashmi Kanagal-Shamanna and 2024 Program Chair and President-Elect Jane Houldsworth. Congratulations to Obi Griffith on your your new Past President title! #CGCAnnual2023

SAVE THE DAYE!! We’ll see you next year in St. Louis for #CGCAnnual2024 August 4-7, 2024!

#CGCAnnual2023 Day 1 included: 🔬🔥 A captivating session by our invited speaker Dr. Rob Hasserjian on the significance and nuances of NPM1 mutated myeloid malignancies and shaping the future of precision medicine. ✨💫

REGISTER TODAY! Join us for a FREE webinar: Tue, Sep 5, 2023 10:00am PST/1:00pm EST Drs. Ryan Schmidt and Matthew Lebo will discuss recommendations for interpretation of low penetrance variants and risk alleles. Register here or use QR code: mms.cancergenomics.org/members/evr/re…

👉👉👉Brand new paper alert 🚨 from our group ➡️ Ph2 CLIA w/ or w/out #sorafenib for upfront AML therapy || onlinelibrary.wiley.com/doi/10.1002/aj… || led by Tapan Kadia & Hagop Kantarjian,MD MD Anderson Cancer Center #leusm #endcancer | Gautam Borthakur Naval Daver, M.D. Naveen Pemmaraju, MD Nitin Jain Musa Yilmaz, MD

Congratulations Adam L. Booth, MD for your well deserved CAPathologists Resident Advocate Award! #CAP23

📣Join us on Tuesday, October 24, 2023 for the October monthly Collaborative Genomics Conference. This CME-accredited webinar is a join collaboration between UW–Madison and Cancer Genomics Consortium (CGC). Look for the webinar link in your email. Want to submit a case?👉lnkd.in/gHJgwQkn

Thrilled to co-chair #AMP companion society meeting with Dr Adam Fisch at the #USCAP2024 on "Emerging genomic technologies for #Pathology diagnostics" Join us tmrw 4 an insightful discussion Mar 24, 8-10 AM BCC Rm 307 Fab speaker lineup: Drs Haferlach, Smith, Skalova & Faden

Four excellent talks this morning on Emerging Genomic Technologies for Diagnostics in Pathology at Association for Molecular Pathology Companion at #USCAP2024